• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

30/05/2025 12:02

Alembic Pharmaceutic - Press Release

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 30, 2025, titled ""Alembic Pharmaceuticals receives USFDA Final Approval for Bosutinib Tablets, 100 mg and 500 mg"".